8-K
filed January 10, 2025, 6:59 PM ET
ticker GENC
CIK 0000064472
other material
confidence high
sentiment negative
materiality 0.60
Gencor receives NYSE American delinquency notice for late 10-K filing; six months to comply
GENCOR INDUSTRIES INC
- NYSE American notified Gencor on Jan 3, 2025, that it failed to timely file Form 10-K for FY2024 by Dec 31, 2024 extension deadline.
- Company has six months from Dec 31, 2024, to regain compliance by filing the 10-K; NYSE may grant up to six additional months.
- NYSE may commence delisting proceedings at any time if circumstances warrant; no immediate effect on trading.
- Company expects to file the Form 10-K within the six-month period but no assurance given.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-25-004061
- form_type
- 8-K
- ticker
- GENC
- cik
- 0000064472
- company_name
- GENCOR INDUSTRIES INC
- filed_at
- 2025-01-10T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:06.076386+00:00
- generated_at
- 2026-05-28T05:53:34.048153+00:00
- sec_items
- ["3.01", "7.01", "9.01"]
- event_type
- other_material
- sentiment
- negative
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-25-004061
- json_url
- https://secwatch.observer/filing/0001193125-25-004061.json
- markdown_url
- https://secwatch.observer/filing/0001193125-25-004061.md
- text_url
- https://secwatch.observer/filing/0001193125-25-004061.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/64472/000119312525004061/0001193125-25-004061-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/64472/000119312525004061/d884845d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
ISPC
iSpecimen prices $2.5M private placement at $5.12/share; regains Nasdaq minimum bid price compliance
iSpecimen Inc.
May 13, 2026, 5:00 PM ET
other_material
Items 1.01, 3.01, 3.02, 7.01, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01, 9.01
same event type: other_material
similar materiality
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
minimum $1.00 per share required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum
Bid Price Requirement”) for the prior 30 consecutive business days. On May 12, 2026
Filing page
SEC filing
HCWB
Nasdaq panel grants HCW Biologics extension to July 29, 2026 to regain $1 bid price compliance
HCW Biologics Inc.
June 1, 2026, 7:30 AM ET
other_material
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
ng the exception period that may
affect the Company’s compliance with Nasdaq requirements. If the Company regains compliance and satisfies the terms of the exception,
the Panel intends to impose a Discretionary Panel Monitor on the Company for an additional one-year period, pursuant to Listing Rule
5815(d)(4)(A). SIGNATURES Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. HCW BIOLOGICS INC. Date: June 1, 2026 By: /s/
Hing C. Wong Hing C. Wong, Founder and Chie
Filing page
SEC filing
TNON
Tenon Medical receives Nasdaq delisting notice for failing minimum stockholders' equity
Tenon Medical, Inc.
May 22, 2026, 5:15 PM ET
other_material
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
May 21, 2026, Tenon Medical, Inc. (the “Company”)
received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) dated May 21, 2026, notifying
the Company that it is no longer in compliance with the
Filing page
SEC filing
HUMA
Humacyte receives Nasdaq deficiency notice for bid price below $1.00; 180 days to comply
Humacyte, Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: other_material
similar materiality
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
May 4, 2026, Humacyte, Inc. (the “Company”)
received a letter from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) providing notification
that, for the 30 consecutive business days ended May 1, 2026, th
Filing page
SEC filing
EMAT
Evolution Metals regains Nasdaq compliance after late 10-Q filing; notice resolved
Evolution Metals & Technologies Corp.
May 26, 2026, 5:28 PM ET
other_material
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01, 9.01
same event type: other_material
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
May 21, 2026, Evolution Metals & Technologies
Corp. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The
Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that
Filing page
SEC filing
AGAE
AIFA gets Nasdaq delisting notice for late filings; later files FY 2025 10-K
Allied Gaming & Entertainment Inc.
May 21, 2026, 9:40 PM ET
other_material
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01, 9.01
same event type: other_material
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
May 19, 2026, All In FutureTech Alliance,
Inc. (formerly known as Allied Gaming & Entertainment Inc., the “Company”) received a deficiency letter (the “Letter”)
from the Listing Qualifications Department (the “Staff”) of
Filing page
SEC filing
PMI
Picard Medical Q1 revenue up 85% to $1.2M; reports $1.4M negative equity, NYSE listing notices
Picard Medical, Inc.
May 21, 2026, 4:15 PM ET
other_material
Items 2.02, 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01, 9.01
same event type: other_material
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
reviously disclosed, on May
8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together
with the May 15 Notice, the “ Notices ”). In connection with the
Filing page
SEC filing
BKYI
BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13
BIO KEY INTERNATIONAL INC
May 12, 2026, 4:46 PM ET
other_material
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 7.01, 9.01
same event type: other_material
This filing
January 3, 2025, the Company received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company is not in compliance with the NYSE American LLC (“NYSE American”) continued listing
Comparable filing
May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.